Egypt Healthcare, Regulatory and Reimbursement Landscape

Summary

The publisher, the industry analysis specialist, has released its latest report, “Egypt Healthcare, Regulatory and Reimbursement Landscape - CountryFocus”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Egypt. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by the publisher's team of industry experts.

The Egyptian pharmaceutical market was valued at EGP44.70B ($2.66B) in 2019, which is estimated to increase at a Compound Annual Growth Rate (CAGR) of 8% to EGP56.60B ($3.37B) in 2022. The market value is expected to increase further to $3.94B by 2024. The pharmaceutical market value is attributed to the growing population, increased prevalence of chronic diseases, new product development in the pharmaceutical and medical devices sector, and implementation of universal health coverage. However, currency fluctuation, generics substitution, and counterfeit medicines are barriers to the growth of the Egyptian pharmaceutical market.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Egypt, and includes:
An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Novartis, GSK, Sanofi, Pharco, and Amoun
Profiles and SWOT analyses of the major players in the medical device market: Abbott, GE Healthcare, Fresenius, Roche Diagnostics, and Alcon
An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the Egyptian healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

Develop business strategies by understanding the trends shaping and driving Egypt’s healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Egypt’s healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

1. Table of Contents

1.1 List of Figures
1.2 List of Tables

2. Executive Summary

2.1 Executive Summary-Overview
2.2 Key Highlights-Facts About the Egyptian Healthcare Market
2.3 Key Highlights: Healthcare Startups in Egypt
2.4 Key Events: Egyptian Healthcare Timeline, 2014-2020
2.5 Key Events: Egyptian Pharmaceutical Market
2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Egypt, 2019

3. Overview of Pharmaceutical Market

3.1 Pharmaceutical Market-Overview
3.2 Pharmaceutical Market-Exports
3.3 Pharmaceutical Market-Imports
3.4 Pharmaceutical Market-Supply Channels, Egypt
3.5 Pharmaceutical Market-Market Segments
3.6 Major Therapeutic Areas, Egypt
3.7 COVID-19 Epidemiology, Egypt
3.8 COVID-19 Impact and Developments in the Healthcare Market, Egypt
3.9 COVID-19 Clinical Trials Landscape, Egypt
3.10 Pharmaceutical Market-Major Players

4. Overview of Medical Devices Market

4.1 Medical Device Market-Overview
4.2 Medical Devices Market-Major Players

5. Pharmaceutical and Medical Devices Market-Drivers and Barriers

5.1 Drivers
5.2 Barriers

6. Deal Analysis

6.1 Deal Analysis: Pharmaceutical Market, Egypt, 2019-2020
6.2 Deal Analysis: Medical Device Market, Egypt, 2019-2020

7. HealthTech Landscape

7.1 HealthTech Deals Landscape, Egypt
7.2 Key HealthTech Deals, Egypt
7.3 Adoption of Technology in Healthcare, Egypt
7.4 Key Developments: Technology in Healthcare, Egypt
7.5 Regulatory Scenario Covering Use of Technology in Healthcare, Egypt
7.6 HealthTech Landscape: Benefits and Risks, Egypt

8. Market Access

8.1 Overview of Healthcare System, Egypt
8.2 Reimbursement Process, Egypt
8.3 Overview of Public and Private Insurance Providers, Egypt
8.4 Healthcare Spending and Medicine Price Index, Egypt
8.5 Pricing Policies, Egypt
8.6 Regulatory Landscape, Egypt
8.6.1 Overview of Regulatory Agencies
8.6.2 Regulatory Landscape, Egypt
8.6.3 Market Authorization for Pharmaceutical Drugs, Egypt
8.6.4 Market Authorization for Medical Devices, Egypt
8.6.5 Intellectual Property Rights, Patent, Egypt
8.6.6 Intellectual Property Rights, Trademark, Egypt
8.6.7 Clinical Trials Regulation, Egypt
8.6.8 Pharmaceutical Clinical Trials Landscape, Egypt
8.6.9 Medical Devices Clinical Trials Landscape, Egypt
8.6.10 Pharmaceutical Product Import Regulations, Egypt
8.6.11 Pharmaceutical Product Export Regulations, Egypt
8.6.12 Pharmaceutical Advertisement Regulations, Egypt
8.6.13 Labeling and Packaging Regulations, Egypt

9. Country Healthcare Landscape

9.1 Healthcare Policy Highlights, Egypt
9.2 Healthcare Facilities, Egypt
9.3 Healthcare Parameters, Egypt
9.4 Life Expectancy and Immunization Rate, Egypt
9.5 Environmental Health, Egypt
9.6 Healthcare Personnel, Egypt
9.7 Disease Burden, Egypt
9.8 Healthcare Expenditure, Egypt

10. Trade Associations, Egypt11. Trade Fairs, Egypt12. Opportunities and Challenges

13. Appendix

13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.2 Bibliography
13.3 About the Publisher
13.4 Contact
13.5 Disclaimer

List of Tables

Table 1: Price Mark-ups, Egypt, 2018
Table 2: Approved Biologics, Egypt, 2018
Table 3: Approved Biosimilars, Egypt, 2016
Table 4: Major Therapeutic Areas by Costs of Treatment, Egypt, 2018
Table 5: COVID-19 Indicators (Number of cases), Global and Egypt, 2020
Table 6: COVID-19 IVD Products, Egypt, 2020
Table 7: Medical Device Market, Egypt, Major Segments ($M), 2019
Table 8: In Vitro Diagnostics Market, Egypt, Revenue ($M) and Market Share (%) of Major Sectors, 2019
Table 9: Cardiovascular Devices Market, Egypt, Revenue ($M) and Market Share (%) of Major Sectors, 2019
Table 10: General Surgery Market, Egypt, Revenue ($M) and Market Share (%) of Major Sectors, 2019
Table 11: Orthopedic Devices Market, Egypt, Revenue ($M) and Market Share (%) of Major Sectors, 2019
Table 12: Wound Care Management Market, Egypt, Revenue ($M) and Market Share (%) of Major Sectors, 2019
Table 13: Classification of Medical Device, Egypt, 2020
Table 14: Patent Fees, Egypt, 2020
Table 15: Outer Label, Egypt, 2020
Table 16: Number of Beds by Sector, Egypt, 2017

List of Figures

Figure 1: Pharmaceutical Market, Egypt, Revenue ($B), 2012-2019
Figure 2: Medical Device Market, Egypt, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Egypt, 2020
Figure 4: Number of Deals (2019-2020)
Figure 5: 2019-2020 Deal Overview by Region
Figure 6: Country Profile, Egypt, 2019
Figure 7: Pharmaceutical Market, Egypt, Revenue ($B), 2012-2019
Figure 8: Pharmaceutical Market, Egypt, Revenue Forecast ($B), 2020-2024
Figure 9: Pharmaceutical Exports ($B), Egypt, 2012-2019
Figure 10: Top Export Partners, Egypt, 2019
Figure 11: Pharmaceutical Imports ($B), Egypt, 2012-2019
Figure 12: Top Import Partners, Egypt, 2019
Figure 13: Supply Channels, Egypt, 2019
Figure 14: OTC Market, Egypt, Revenue ($B), 2012-2018
Figure 15: OTC Market by Drug Category, Egypt, Revenue ($M), 2018
Figure 16: Major Therapeutic Areas by Costs of Treatment, Egypt, 2018
Figure 17: COVID-19 (cases), Egypt, 2020
Figure 18: COVID-19 (deaths), Egypt, 2020
Figure 19: COVID-19 Clinical Trials Count By Phase, Egypt, 2020
Figure 20: COVID-19 Clinical Trials Count By Trial Status, Egypt, 2020
Figure 21: Top Five COVID-19 Clinical Trials Sponsors By Count, Egypt, 2020
Figure 22: Medical Device Market, Egypt, Revenue ($B), 2015-2020
Figure 23: Medical Device Market, Egypt, Revenue Forecast ($B), 2021-2025
Figure 24: Medical Device Market, Egypt, Major Segments (%), 2019
Figure 25: In Vitro Diagnostics Market, Egypt, Revenue ($M), 2015-2022
Figure 26: In Vitro Diagnostics Market, Egypt, Market Share of Major Sectors (%), 2019
Figure 27: Cardiovascular Devices Market, Egypt, Revenue ($M), 2015-2022
Figure 28: Cardiovascular Devices Market, Egypt, Market Share of Major Sectors (%), 2019
Figure 29: General Surgery Market, Egypt, Revenue ($M), 2015-2022
Figure 30: General Surgery Market, Egypt, Market Share of Major Sectors (%), 2019
Figure 31: Orthopedic Devices Market, Egypt, Revenue ($M), 2015-2022
Figure 32: Orthopedic Devices Market, Egypt, Market Share of Major Sectors (%), 2019
Figure 33: Wound Care Management Market, Egypt, Revenue ($M), 2015-2022
Figure 34: Wound Care Management Market, Egypt, Market Share of Major Sectors (%), 2019
Figure 35: Diagnostic Market, Egypt, Revenue ($M), 2015-2020
Figure 36: Diagnostic Market, Egypt, Revenue ($M), 2021-2025
Figure 37: Medical Devices Market, Egypt, Revenue ($B) of Major Companies, 2019
Figure 38: Deal Value and Deal Count, Pharmaceutical Market, Egypt, 2019-2020
Figure 39: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Egypt, 2019-2020
Figure 40: Top Therapy Areas by Deal Value and Deal Count, Pharmaceutical Market, Egypt, 2019-2020
Figure 41: Deal Value ($M), HealthTech, Egypt, 2019-2020
Figure 42: Deal Count ($M), HealthTech, Egypt, 2019-2020

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€1957EUR$1,995USD£1,628GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€3915EUR$3,990USD£3,256GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5872EUR$5,985USD£4,884GBP

Table of Contents

Related Topics

Related Reports

Healthcare Reimbursement Market by Claim, Payer, Service Provider - Global Forecast 2025-2030

Medical Billing Market by Offerings, Type, Deployment, Application, End-User - Global Forecast 2025-2030

Behavioral Health Market Size, Share & Trends Analysis Report By Age Group, By Disorder (Substance Abuse Disorders, Alcohol Use Disorders, Eating Disorders, ADHD and Others), By Service, By Regional Outlook and Forecast, 2023 - 2030

LAMEA Behavioral Health Market Size, Share & Trends Analysis Report By Age Group, By Disorder (Substance Abuse Disorders, Alcohol Use Disorders, Eating Disorders, ADHD and Others), By Service, By Country and Growth Forecast, 2023 - 2030

Medical Case Management Service Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, and Product Type